Literature DB >> 9596048

Treatment of depressive symptoms in human immunodeficiency virus-positive patients.

J C Markowitz1, J H Kocsis, B Fishman, L A Spielman, L B Jacobsberg, A J Frances, G L Klerman, S W Perry.   

Abstract

BACKGROUND: This randomized clinical trial compared 16-week interventions with interpersonal psychotherapy, cognitive behavioral therapy, supportive psychotherapy, and supportive psychotherapy with imipramine for human immunodeficiency virus (HIV)-positive patients with depressive symptoms.
METHODS: Subjects (N = 101; 85 male, 16 female) with known HIV seropositivity for at least 6 months were randomized to 16 weeks of treatment. Inclusion criteria were 24-item Hamilton Depression Rating Scale score of 15 or higher, clinical judgment of depression, and physical health sufficient to attend outpatient sessions. Therapists were trained in manualized therapies specific for HIV-positive patients. Treatment adherence was monitored.
RESULTS: Subjects randomized to interpersonal psychotherapy (n = 24) and supportive psychotherapy with imipramine (n = 26) had significantly greater improvement on depressive measures than those receiving supportive psychotherapy (n = 24) or cognitive behavioral therapy (n = 27). Similar results appeared in the completer subsample.
CONCLUSIONS: Depressive symptoms appear treatable in HIV-positive patients. Interpersonal psychotherapy may have particular advantages as a psychotherapy for patients who have experienced the significant life events of HIV infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9596048     DOI: 10.1001/archpsyc.55.5.452

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  52 in total

Review 1.  Psychopharmacological treatment of patients with HIV and AIDS.

Authors:  Stephen J Ferrando; Khakasa Wapenyi
Journal:  Psychiatr Q       Date:  2002

2.  Interpersonal psychotherapy: principles and applications.

Authors:  John C Markowitz; Myrna M Weissman
Journal:  World Psychiatry       Date:  2004-10       Impact factor: 49.548

3.  Challenges in addressing depression in HIV research: assessment, cultural context, and methods.

Authors:  Jane M Simoni; Steven A Safren; Lisa E Manhart; Karen Lyda; Cynthia I Grossman; Deepa Rao; Matthew J Mimiaga; Frank Y Wong; Sheryl L Catz; Michael B Blank; Ralph DiClemente; Ira B Wilson
Journal:  AIDS Behav       Date:  2011-02

4.  The future of psychotherapies for mood disorders.

Authors:  Myrna M Weissman; John C Markowitz
Journal:  World Psychiatry       Date:  2003-02       Impact factor: 49.548

Review 5.  When should psychotherapy be the treatment of choice for major depressive disorder?

Authors:  John C Markowitz
Journal:  Curr Psychiatry Rep       Date:  2008-12       Impact factor: 5.285

Review 6.  A systematic review of research findings on the efficacy of interpersonal therapy for depressive disorders.

Authors:  Marcelo Feijo de Mello; Jair de Jesus Mari; Josue Bacaltchuk; Helen Verdeli; Richard Neugebauer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-11-12       Impact factor: 5.270

7.  Pain and depression in gynecology patients.

Authors:  Ellen L Poleshuck; Matthew J Bair; Kurt Kroenke; Arthur Watts; Xin Tu; Donna E Giles
Journal:  Psychosomatics       Date:  2009 May-Jun       Impact factor: 2.386

Review 8.  [Antidepressants for treatment of depression in palliative patients : a systematic literature review].

Authors:  M Ujeyl; B Müller-Oerlinghausen
Journal:  Schmerz       Date:  2012-09       Impact factor: 1.107

9.  A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals.

Authors:  Steven A Safren; Conall O'Cleirigh; Judy Y Tan; Sudha R Raminani; Laura C Reilly; Michael W Otto; Kenneth H Mayer
Journal:  Health Psychol       Date:  2009-01       Impact factor: 4.267

10.  Adjustment Disorder: epidemiology, diagnosis and treatment.

Authors:  Mauro Giovanni Carta; Matteo Balestrieri; Andrea Murru; Maria Carolina Hardoy
Journal:  Clin Pract Epidemiol Ment Health       Date:  2009-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.